Quantum Biopharma (QNTM) Depreciation & Amortization (CF) (2019 - 2026)
Quantum Biopharma (QNTM) posted Depreciation & Amortization (CF) of $127436.0 for Q1 2026, down 12.32% sequentially from $145336.0 in Q3 2025, and down 1.74% YoY from $129690.0 in Q1 2025.
Quantum Biopharma (QNTM) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Depreciation & Amortization (CF) for 8 years, with the latest figure at $127436.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | 128,368.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127,436.00 |
| Mar 31, 2026 | 127,436.00 |
| Sep 30, 2025 | 145,336.00 |
| Sep 30, 2025 | 145,336.00 |
| Jun 30, 2025 | 141,383.00 |
| Jun 30, 2025 | 141,383.00 |
| Mar 31, 2025 | 129,690.00 |
| Mar 31, 2025 | 129,690.00 |
| Sep 30, 2024 | 120,814.00 |
| Sep 30, 2024 | 120,814.00 |
| Jun 30, 2024 | 136,813.00 |
| Jun 30, 2024 | 136,813.00 |
| Mar 31, 2024 | 120,141.00 |
| Mar 31, 2024 | 120,141.00 |
| Sep 30, 2023 | 146,810.00 |
| Sep 30, 2023 | 146,810.00 |
| Jun 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Mar 31, 2023 | 1.13 Mn |